.svg){kind=small}
Jun-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In June 2026, Kind Medicine concentrated 82.09% of sales in Tincture & Sublingual, where year-over-year sales declined 4.94% but month-over-month grew 24.00%, while Topical held 14.14% share with a 17.58% YoY decline and a 106.25% MoM surge; Capsules fell to 3.76% share with a 94.55% YoY drop and a 78.50% MoM decline. The brand’s average price rose 16.10% YoY to $33.81, and within Tincture & Sublingual the average price was $34.19, positioning the mix to lean into higher-priced sublinguals while trimming exposure to Capsules; this pattern implies a shift toward formats with steadier MoM velocity and away from lagging Capsules despite broad YoY contraction of 42.03%.
Given a number 20 rank in California Tincture & Sublingual and an 82.09% category dependence, the month-over-month rebound of 24.00% in that category alongside a 106.25% Topical MoM spike suggests a near-term positioning anchored in sublinguals with opportunistic Topical expansion. With Capsules contracting 94.55% YoY and losing 78.50% MoM, the portfolio appears to be consolidating around two use-cases—sublingual routines and topical relief—where higher average prices of $34.19 in Tincture & Sublingual and $30.79 in Topical can support mix-driven revenue even as overall brand sales fell 42.03% YoY; this implies focus on depth in Tincture & Sublingual and selective Topical pushes to stabilize rank and share within California.
Competitive Landscape
Kind Medicine sits at rank #20 in California Tincture & Sublingual for June 2026, down 2 positions year over year from #18 and up 1 position versus March 2026’s #21; against this, category leaders moved differently, as Papa & Barkley held #1 year over year while its sales fell 9.7%, and ABX / AbsoluteXtracts advanced from #7 to #5 with a 10.3% sales increase. Kind Medicine’s current #20 also trails its April 2025 peak of #17 by 3 ranks, while competitors like Yummi Karma stayed at #2 with 3.3% sales growth and Care By Design remained #3 despite a 9.6% decline, indicating the brand’s modest quarter-over-quarter climb has not translated into category share capture relative to incumbents expanding or defending higher slots. The pattern implies Kind Medicine’s rank trajectory is stabilizing below prior highs, signaling that incremental gains without sharper differentiation against top-5 movers will likely cap near-term upside in placement.
Notable Products
Menthol Rub (400mg THC, 60ml) posted the largest movement in June 2026 with a 184.75% month-over-month surge that vaulted it to rank 3, while Indica Tincture (1000mg THC,30ml) slid 22.9% yet held rank 1. Indica Tincture (800mg THC,30ml) climbed 46.0% to rank 2, and the CBD/THC 25:1 Pet Tincture (500mg CBD, 20mg THC, 30ml) rose 36.5% to rank 2 in its lane with $2,278 in sales. Four of the top six products are Tincture & Sublingual SKUs, and Sativa Tincture (1000mg THC, 30ml) added 15.9% at rank 6 while Sativa Tincture (800mg THC, 30ml) grew 11.6% at rank 5. The pattern implies Kind Medicine is broadening beyond a tincture-led base toward a more diversified basket where topical breakthroughs can rapidly convert into top-three share.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
